Jan 08, 2026 15:06
AXSM - Axsome Therapeutics, Inc
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 143.9 4.89 (3.4%) | 0.04 (0.03%) | 0.2 (0.13%) | 0.49 (0.33%) | --- | 4.89 (3.4%) | 0.0 (0.0%) | 0.0 (0.0%) |
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.97
- Diluted EPS:
- -0.97
- Basic P/E:
- -153.3918
- Diluted P/E:
- -153.3918
- RSI(14) 1m:
- 60.54
- VWAP:
- 148.75
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Jan 08, 2026 10:15
Dec 31, 2025 12:00
Dec 02, 2025 01:06
Nov 20, 2025 12:00
Sep 30, 2025 08:10
Sep 13, 2025 00:12
Aug 27, 2025 11:00
Jun 20, 2025 11:00
Jun 11, 2025 11:00